Lactobacillus rhamnosus GG

Lactobacillus rhamnosus often has pilus-like adhesion structures that cling to intestinal epithelium and compete with pathogens for attachment sites. Human data are most used for acute childhood diarrhea, antibiotic-associated diarrhea, and traveler's gut upset. Shorter illness and fewer stools are the more often observed markers. In the acute phase, watery-stool frequency can be assessed within a few days.

Some studies have watched natural-killer-cell activity, secretory immunoglobulin, and eczema incidence in young children. Immune orientation from pregnancy through lactation or infancy is a common extended use of this species. Felt effects usually fall on seasonal skin and airway discomfort. Seasonal swings of skin and nose usually take several continuous weeks to show direction.

Lactobacillus rhamnosus trials partly start in pregnancy or infancy, watching eczema incidence and skin-barrier markers. Beyond diarrhea and mucosal immunity, families with allergy-prone toddlers who want gut-directed immunity often match gaps on this skin-allergy path; direction is easier to see after several continuous weeks.